Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy

Top stories of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/hep-c-melanoma-drug-approvals-highlight-week-in-sp" target="_blank">View the story "Hep C, Melanoma Drug Approvals Highlight Week in Specialty Pharmacy" on Storify</a>]

Related Content:

Specialty Pharmacy
Establishing Workflow for In-clinic, Home Administration of Cabotegravir-rilpivirine Injections for HIV-1
Updates in Prevention, Treatment of Cytokine Release Syndrome, Neurologic Toxicities for Patients With Multiple Myeloma
Study: Ibrutinib Effective Treatment for Difficult to Treat Forms of Hairy Cell Leukemia